Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase - Differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin

被引:87
作者
Cardounel, AJ
Xia, Y
Zweier, JL
机构
[1] Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Pharmacol, Columbus, OH 43210 USA
关键词
D O I
10.1074/jbc.M410241200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endogenous methylarginines asymmetric dimethylarginine ( ADMA) and N-G-monomethyl-L-arginine ( L-NMMA) regulate nitric oxide ( NO) production from neuronal NO synthase ( nNOS). Under conditions of L-arginine or tetrahydrobiopterin ( BH4) depletion, nNOS also generates superoxide, O-2(radical anion) ; however, the effects of methylarginines on this O-2(radical anion) generation are poorly understood. Therefore, we measured the dose-dependent effects of ADMA and L-NMMA on the rate and amount of O-2(radical anion) production from nNOS under conditions of L-arginine and/or BH4 depletion, using electron paramagnetic resonance spin trapping. In the absence of L-arginine, ADMA ( 1 muM) inhibited O-2(radical anion) generation by similar to 60% from a rate of 56 to 23 nmol/mg/min, whereas L-NMMA ( 0.1 - 100 muM) had no effect. L-Arginine markedly decreased the observed O-2(radical anion), adduct formation; however, O-2. generation from the enzyme still occurs at a low rate ( 12.1 nmol/mg/min). This O-2(radical anion) leak is NOS-derived as it is not seen in the absence of calcium and calmodulin and demonstrates that O-2(radical anion) generation from NOS occurs even when normal substrate/cofactor levels are present. Under conditions of BH4 depletion, ADMA had no effect on O-2(radical anion), whereas L-NMMA increased O-2(radical anion) production almost 3-fold. This O-2(radical anion) generation was > 90% inhibited by imidazole, indicating that it occurred at the heme center. Thus, methylarginines can profoundly shift the balance of NO and O-2(radical anion) generation from nNOS. These observations have important implications with regard to the therapeutic use of methylarginine-NOS inhibitors in the treatment of disease.
引用
收藏
页码:7540 / 7549
页数:10
相关论文
共 46 条
[1]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[2]   Enzymatic function of nitric oxide synthases [J].
Andrew, PJ ;
Mayer, B .
CARDIOVASCULAR RESEARCH, 1999, 43 (03) :521-531
[3]   N-G-Nitro-L-[H-3]arginine binding properties of neuronal nitric oxide synthase in rat brain [J].
Arima, T ;
Kitamura, Y ;
Nishiya, T ;
Kiriyama, Y ;
Taniguchi, T ;
Nomura, Y .
NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (03) :239-245
[4]   Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase [J].
Böger, RH ;
Vallance, P ;
Cooke, JP .
ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (04) :1-3
[5]   Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury [J].
Cardounel, AJ ;
Zweier, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33995-34002
[6]   Does ADMA cause endothelial dysfunction? [J].
Cooke, JP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) :2032-2037
[7]   Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation [J].
Fischmann, TO ;
Hruza, A ;
Niu, XD ;
Fossetta, JD ;
Lunn, CA ;
Dolphin, E ;
Prongay, AJ ;
Reichert, P ;
Lundell, DJ ;
Narula, SK ;
Weber, PC .
NATURE STRUCTURAL BIOLOGY, 1999, 6 (03) :233-242
[8]   Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase [J].
Flinspach, ML ;
Li, HY ;
Jamal, J ;
Yang, WP ;
Huang, H ;
Hah, JM ;
Gómez-Vidal, JA ;
Litzinger, EA ;
Silverman, RB ;
Poulos, TL .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (01) :54-59
[9]   Electrochemistry of pterin cofactors and inhibitors of nitric oxide synthase [J].
Gorren, ACF ;
Kungl, AJ ;
Schmidt, K ;
Werner, ER ;
Mayer, B .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2001, 5 (02) :176-186
[10]  
HASEGAWA T, 1992, BIOCHEM INT, V26, P653